お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
1006159

呼吸器疾患検査の世界市場:製品 (血液ガス検査、画像検査、呼吸測定)、エンドユーザー (臨床検査室、病院) 別の予測(2026年まで)- COVID-19の累積的影響

Respiratory Disease Testing Market Research Report by Product, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 191 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.33円
呼吸器疾患検査の世界市場:製品 (血液ガス検査、画像検査、呼吸測定)、エンドユーザー (臨床検査室、病院) 別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の呼吸器疾患検査の市場規模は、2020 年の 36 億 1,787 万米ドルから 2025 年末までに 42 億 7,788 万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた未曾有の世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。当レポートでは、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げ消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19の影響について考察しています。

当レポートは、世界の呼吸器疾患検査市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、製品・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文に

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • ステークホルダー

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査器具
    • 収集: データ ソース
    • 分析: データ解釈
    • 策定: データ検証
    • 発行:調査報告書
    • 繰り返し: レポートの更新
  • 調査実施
    • 開始:調査プロセス
    • 計画:調査計画の策定
    • 実行:調査の実施
    • 検証: 発見と分析
    • 発行:調査報告書
  • 調査成果

第3章 エグゼクティブサマリー

  • 市場展望
  • エンドユーザー別市場の展望
  • 製品別市場の展望
  • 地域別市場の展望
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的な影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 製品別市場

  • 血液ガス検査
  • 画像検査
  • 呼吸測定

第7章 エンドユーザー別市場

  • 臨床検査室
  • 病院

第8章 南北アメリカ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域市場

  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第10章 欧州、中東・アフリカ市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNV ポジショニング マトリックス
    • 象限
    • 事業戦略
    • 製品満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、パートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第12章 企業プロファイル

  • Abbott Laboratories
  • Alere Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux
  • CareFusion Corporation
  • Carestream Medical
  • Cosmed
  • Fisher & Paykel Healthcare Limited
  • Fujifilm Holdings
  • GE Healthcare
  • Hitachi Medical Corporation
  • Koninklijke Philips N.V
  • Medtronic Plc
  • MGC Diagnostics Corporation
  • ResMed
  • Sdi Diagnostics
  • Seegene Inc.
  • SELUTEC GmbH
  • Shimadzu Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.
  • Toshiba Medical Systems Corporation

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格
  • 連絡先の詳細
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2026
  • FIGURE 19. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 24. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 26. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. CALIFORNIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. FLORIDA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. ILLINOIS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. NEW YORK RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. OHIO RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. PENNSYLVANIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. TEXAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 39. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 41. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 50. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 52. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. GLOBAL RESPIRATORY DISEASE TESTING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 64. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 65. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CALIFORNIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CALIFORNIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. FLORIDA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. FLORIDA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ILLINOIS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ILLINOIS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. NEW YORK RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. NEW YORK RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. OHIO RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. OHIO RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. PENNSYLVANIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. PENNSYLVANIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. TEXAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. TEXAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SCORES
  • TABLE 83. GLOBAL RESPIRATORY DISEASE TESTING MARKET: BUSINESS STRATEGY
  • TABLE 84. GLOBAL RESPIRATORY DISEASE TESTING MARKET: PRODUCT SATISFACTION
  • TABLE 85. GLOBAL RESPIRATORY DISEASE TESTING MARKET: RANKING
  • TABLE 86. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 87. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY COMPANY, 2020
  • TABLE 88. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MERGER & ACQUISITION
  • TABLE 89. GLOBAL RESPIRATORY DISEASE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 90. GLOBAL RESPIRATORY DISEASE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 91. GLOBAL RESPIRATORY DISEASE TESTING MARKET: INVESTMENT & FUNDING
  • TABLE 92. GLOBAL RESPIRATORY DISEASE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 93. GLOBAL RESPIRATORY DISEASE TESTING MARKET: LICENSE & PRICING
  • TABLE 94. GLOBAL RESPIRATORY DISEASE TESTING MARKET: CONTACT DETAILS
目次
Product Code: MRR-035AB9C0DAAE

The Global Respiratory Disease Testing Market size was estimated at USD 3,617.87 Million in 2020 and expected to reach USD 3,759.27 Million in 2021, at a Compound Annual Growth Rate (CAGR) 4.24% to reach USD 4,643.28 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Respiratory Disease Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Respiratory Disease Testing Market was studied across Blood Gas Test, Imaging Tests, and Respiratory Measurement.

Based on End-User, the Respiratory Disease Testing Market was studied across Clinical Laboratories and Hospitals.

Based on Geography, the Respiratory Disease Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Respiratory Disease Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Disease Testing Market, including Abbott Laboratories, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux, CareFusion Corporation, Carestream Medical, Cosmed, Fisher & Paykel Healthcare Limited, Fujifilm Holdings, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips N.V, Medtronic Plc, MGC Diagnostics Corporation, ResMed, Sdi Diagnostics, Seegene Inc., SELUTEC GmbH, Shimadzu Corporation, Siemens Healthcare, Thermo Fisher Scientific Inc., and Toshiba Medical Systems Corporation.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Respiratory Disease Testing Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Disease Testing Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Disease Testing Market?
  • 4. What is the competitive strategic window for opportunities in the Global Respiratory Disease Testing Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Respiratory Disease Testing Market?
  • 6. What is the market share of the leading vendors in the Global Respiratory Disease Testing Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Respiratory Disease Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End-User Outlook
  • 3.4. Product Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of respiratory diseases
      • 5.1.1.2. Adoption of unhealthy lifestyle and habits such as tobacco smoking
      • 5.1.1.3. Constantly rising air pollution levels
      • 5.1.1.4. Major adoption of imaging technology for diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternatives systems and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising preferences for remote or home care testing devices
      • 5.1.3.2. R&D and technology advancements in testing methods for effective, efficient, and faster results
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of supportive reimbursement policies
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Respiratory Disease Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Gas Test
  • 6.3. Imaging Tests
  • 6.4. Respiratory Measurement

7. Respiratory Disease Testing Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinical Laboratories
  • 7.3. Hospitals

8. Americas Respiratory Disease Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Respiratory Disease Testing Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Respiratory Disease Testing Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Alere Inc.
  • 12.3. Becton, Dickinson and Company
  • 12.4. Bio-Rad Laboratories, Inc.
  • 12.5. Biomerieux
  • 12.6. CareFusion Corporation
  • 12.7. Carestream Medical
  • 12.8. Cosmed
  • 12.9. Fisher & Paykel Healthcare Limited
  • 12.10. Fujifilm Holdings
  • 12.11. GE Healthcare
  • 12.12. Hitachi Medical Corporation
  • 12.13. Koninklijke Philips N.V
  • 12.14. Medtronic Plc
  • 12.15. MGC Diagnostics Corporation
  • 12.16. ResMed
  • 12.17. Sdi Diagnostics
  • 12.18. Seegene Inc.
  • 12.19. SELUTEC GmbH
  • 12.20. Shimadzu Corporation
  • 12.21. Siemens Healthcare
  • 12.22. Thermo Fisher Scientific Inc.
  • 12.23. Toshiba Medical Systems Corporation

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.